Analyzing the current practice patterns and views among urologists regarding focal therapy for prostate cancer
The widespread use of prostate-specific antigen screening has led to an earlier and increased diagnosis of low-risk prostate cancer (CaP) [1,2]. While urologists have increasingly been using active surveillance for very low-risk and low-risk disease, whole gland treatment (WGT) by means of radical prostatectomy and radiation therapy is still widely used for high volume low-risk and low volume intermediate-risk CaP. However, the risk of CaP mortality in these populations is low [3,4]. These patients may ultimately receive WGT because of several reasons, including, but not limited to, concerns of the patient and physician, young patient age, and strong family history [3,5].
Source: Urologic Oncology: Seminars and Original Investigations - Category: Urology & Nephrology Authors: Amit L. Jain, Abhinav Sidana, Mahir Maruf, Dordaneh Sugano, Brian Calio, Bradford J. Wood, Peter A. Pinto Tags: Clinical-Prostate cancer Source Type: research
More News: Cancer | Cancer & Oncology | Prostate Cancer | Prostatectomy | Radiation Therapy | Urology & Nephrology